ACE2 and infection: Infections by both HIV-CoV-1 and HIV-MERS-CoV were elevated by rapalog treatment in HeLa-ACE2 and HeLa-DPP4 cells, respectively, although the extent of enhancement was lower than that observed with HIV-CoV-2 (Figure 4B–C).